| Literature DB >> 28666544 |
Mohammad Javad Hajipour1, Michelle R Santoso2, Farhad Rezaee3, Haniyeh Aghaverdi4, Morteza Mahmoudi5, George Perry6.
Abstract
Alzheimer's disease (AD) is a type of dementia that causes major issues for patients' memory, thinking, and behavior. Despite efforts to advance AD diagnostic and therapeutic tools, AD remains incurable due to its complex and multifactorial nature and lack of effective diagnostics/therapeutics. Nanoparticles (NPs) have demonstrated the potential to overcome the challenges and limitations associated with traditional diagnostics/therapeutics. Nanotechnology is now offering new tools and insights to advance our understanding of AD and eventually may offer new hope to AD patients. Here, we review the key roles of nanotechnologies in the recent literature, in both diagnostic and therapeutic aspects of AD, and discuss how these achievements may improve patient prognosis and quality of life.Entities:
Mesh:
Year: 2017 PMID: 28666544 DOI: 10.1016/j.tibtech.2017.06.002
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536